<code id='048D26644A'></code><style id='048D26644A'></style>
    • <acronym id='048D26644A'></acronym>
      <center id='048D26644A'><center id='048D26644A'><tfoot id='048D26644A'></tfoot></center><abbr id='048D26644A'><dir id='048D26644A'><tfoot id='048D26644A'></tfoot><noframes id='048D26644A'>

    • <optgroup id='048D26644A'><strike id='048D26644A'><sup id='048D26644A'></sup></strike><code id='048D26644A'></code></optgroup>
        1. <b id='048D26644A'><label id='048D26644A'><select id='048D26644A'><dt id='048D26644A'><span id='048D26644A'></span></dt></select></label></b><u id='048D26644A'></u>
          <i id='048D26644A'><strike id='048D26644A'><tt id='048D26644A'><pre id='048D26644A'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:547
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'
          Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

          8:47PresidentJoeBidenspeaksabouttheSupremeCourt'sdecisiontostrikedownrace-consciousstudentadmissions

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Synthetic human embryos? Researchers say term is overblown

          Amouseembryomodelcreatedentirelyfromstemcells.Scientistshavesinceusedsimilarsystemstobuildmodelsofhu